MB-29 RECURRENT MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR: PROLONGED SURVIVAL WITH AN ANTIANGIOGENIC COMBINATION THERAPY

Lignende værker

• ANGI-14 UPDATE ON A METRONOMIC ANTIANGIOGENIC COMBINATION THERAPY FOR RECURRENT MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR
  af: Slavc, Irene, et al.
  Udgivet: (2015)
• OS02.5 Prolonged survival of patients with recurrent medulloblastoma and atypical teratoid rhabdoid tumor treated with an antiangiogenic metronomic combination therapy
  af: Slavc, I., et al.
  Udgivet: (2017)
• INNV-36. A METRONOMIC ANTIANGIOGENIC COMBINATION THERAPY MAY PROLONG SURVIVAL FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR
  af: Slavc, Irene, et al.
  Udgivet: (2018)
• P05.32 Update on a metronomic antiangiogenic combination therapy for recurrent atypical teratoid rhabdoid tumor
  af: Slavc, I, et al.
  Udgivet: (2018)
• OS6.2 Medulloblastoma recurrence: Improved survival with a metronomic and targeted antiangiogenesis therapy - experience in 
18 patients
  af: Slavc, I., et al.
  Udgivet: (2016)